Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 0 | 31,320 | 0 |
| Depreciation Amortization | 0 | 0 | 0 | 177,410 | 0 |
| Other Working Capital | 0 | 0 | 0 | -20,870 | 0 |
| Other Operating Activity | 0 | 0 | 0 | 177,920 | 0 |
| Operating Cash Flow | $0 | $0 | $0 | $365,780 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -81,880 | 0 |
| Net Acquisitions | 0 | 0 | 0 | -2,859,000 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 51,180 | 0 |
| Investing Cash Flow | $0 | $0 | $0 | $-2,889,700 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 2,301,400 | 0 |
| Financing Cash Flow | $0 | $0 | $0 | $2,301,400 | $0 |
| Exchange Rate Effect | 0 | 0 | 0 | -47,690 | 0 |
| Beginning Cash Position | 0 | 0 | 0 | 606,140 | 0 |
| End Cash Position | 0 | 0 | 0 | 335,930 | 0 |
| Net Cash Flow | $0 | $0 | $0 | $-270,210 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 0 | 365,780 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 365,780 | 0 |